Treatment and Diagnosis of MOG-Associated Disorders in Pediatric vs Adult: E. Ann Yeh, MD
The professor of pediatrics in neurology at the University of Toronto discussed differences in disease course, treatment strategy, and trial challenges of MOG-associated disorders in pediatric versus adult patients. [WATCH TIME: 5 minutes] Ann Yeh, MD, a professor of pediatrics in neurology at the University of Toronto, addressed the distinct challenges in diagnosing and treating pediatric patients with MOGAD, emphasizing age-specific considerations.During the meeting, Yeh sat down with NeurologyLive® to outline the diagnostic similarities and key clinical differences between pediatric and adult MOG-associated disorders. Although both groups undergo similar diagnostic evaluations, she noted that pediatric patients may be more likely to present with a monophasic disease course.At the 2025 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, held May 28-31, 2025, in Phoenix, Arizona, the session "MOGAD in Focus: Diagnostic Criteria and Treatment Strategies" offered a comprehensive overview of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Chaired by Eoin P.Then, Flanagan followed with a review of current treatment options and emerging therapies aimed at improving disease management. Additionally, E.
